Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) Stock Competitors & Peer Comparison
See JFNCX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Asset Management - Global Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for JFNCX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| JFNCX | $73.21 | +1.71% | 5.9B | N/A | N/A | N/A |
| IVV | $742.36 | +0.10% | 869.4B | 26.71 | $27.80 | +1.10% |
| VXUS | $83.40 | -0.26% | 642.9B | 17.50 | $4.77 | +2.63% |
| VTI | $364.80 | +0.03% | 624.5B | 25.99 | $14.04 | +1.07% |
| VWO | $57.80 | -0.52% | 160.8B | 16.32 | $3.54 | +2.39% |
| IEMG | $77.05 | -1.78% | 156.3B | 16.70 | $4.61 | +2.34% |
| IWF | $117.65 | -0.79% | 125B | 30.83 | $3.82 | +0.37% |
| RSP | $213.57 | +0.78% | 96.4B | 23.11 | $9.24 | +1.50% |
| VT | $154.20 | -0.07% | 95.7B | 22.01 | $7.00 | +1.61% |
| VEU | $81.62 | -0.23% | 93.4B | 17.64 | $4.63 | +2.60% |
Stock Comparison
iShares Core S&P 500 ETF (AMEX: IVV)
JFNCX vs IVV Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IVV has a market cap of 869.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IVV trades at $742.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IVV's P/E ratio is 26.71. In terms of profitability, JFNCX's ROE is N/A, compared to IVV's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IVV. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IVV's competition here
Vanguard Total International Stock ETF (NASDAQ: VXUS)
JFNCX vs VXUS Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VXUS has a market cap of 642.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VXUS trades at $83.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VXUS's P/E ratio is 17.50. In terms of profitability, JFNCX's ROE is N/A, compared to VXUS's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VXUS. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VXUS's competition here
Vanguard Total Stock Market ETF (AMEX: VTI)
JFNCX vs VTI Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VTI has a market cap of 624.5B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VTI trades at $364.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VTI's P/E ratio is 25.99. In terms of profitability, JFNCX's ROE is N/A, compared to VTI's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VTI. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VTI's competition here
Vanguard FTSE Emerging Markets ETF (AMEX: VWO)
JFNCX vs VWO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VWO has a market cap of 160.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VWO trades at $57.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VWO's P/E ratio is 16.32. In terms of profitability, JFNCX's ROE is N/A, compared to VWO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VWO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VWO's competition here
iShares Core MSCI Emerging Markets ETF (AMEX: IEMG)
JFNCX vs IEMG Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IEMG has a market cap of 156.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IEMG trades at $77.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IEMG's P/E ratio is 16.70. In terms of profitability, JFNCX's ROE is N/A, compared to IEMG's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IEMG. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IEMG's competition here
iShares Russell 1000 Growth ETF (AMEX: IWF)
JFNCX vs IWF Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWF has a market cap of 125B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWF trades at $117.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWF's P/E ratio is 30.83. In terms of profitability, JFNCX's ROE is N/A, compared to IWF's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IWF. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWF's competition here
Invesco S&P 500 Equal Weight ETF (AMEX: RSP)
JFNCX vs RSP Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, RSP has a market cap of 96.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while RSP trades at $213.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas RSP's P/E ratio is 23.11. In terms of profitability, JFNCX's ROE is N/A, compared to RSP's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to RSP. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check RSP's competition here
Vanguard Total World Stock ETF (AMEX: VT)
JFNCX vs VT Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VT has a market cap of 95.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VT trades at $154.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VT's P/E ratio is 22.01. In terms of profitability, JFNCX's ROE is N/A, compared to VT's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VT. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VT's competition here
Vanguard FTSE All-World ex-US ETF (AMEX: VEU)
JFNCX vs VEU Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VEU has a market cap of 93.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VEU trades at $81.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VEU's P/E ratio is 17.64. In terms of profitability, JFNCX's ROE is N/A, compared to VEU's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VEU. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VEU's competition here
iShares Russell 1000 Value ETF (AMEX: IWD)
JFNCX vs IWD Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWD has a market cap of 80B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWD trades at $248.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWD's P/E ratio is 23.11. In terms of profitability, JFNCX's ROE is N/A, compared to IWD's ROE of N/A. Regarding short-term risk, JFNCX is less volatile compared to IWD. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWD's competition here
iShares MSCI EAFE ETF (AMEX: EFA)
JFNCX vs EFA Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, EFA has a market cap of 76.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while EFA trades at $103.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas EFA's P/E ratio is 18.37. In terms of profitability, JFNCX's ROE is N/A, compared to EFA's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to EFA. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check EFA's competition here
First Eagle Global Fund (NASDAQ: SGENX)
JFNCX vs SGENX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SGENX has a market cap of 72.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SGENX trades at $84.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SGENX's P/E ratio is 17.62. In terms of profitability, JFNCX's ROE is N/A, compared to SGENX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to SGENX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check SGENX's competition here
iShares S&P 500 Growth ETF (AMEX: IVW)
JFNCX vs IVW Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IVW has a market cap of 72.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IVW trades at $132.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IVW's P/E ratio is 737.94. In terms of profitability, JFNCX's ROE is N/A, compared to IVW's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IVW. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IVW's competition here
Schwab International Equity ETF (AMEX: SCHF)
JFNCX vs SCHF Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SCHF has a market cap of 65.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SCHF trades at $27.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SCHF's P/E ratio is 18.26. In terms of profitability, JFNCX's ROE is N/A, compared to SCHF's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SCHF. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SCHF's competition here
iShares Core MSCI Total International Stock ETF (NASDAQ: IXUS)
JFNCX vs IXUS Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IXUS has a market cap of 57.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IXUS trades at $93.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IXUS's P/E ratio is 17.66. In terms of profitability, JFNCX's ROE is N/A, compared to IXUS's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IXUS. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IXUS's competition here
iShares Russell Mid-Cap ETF (AMEX: IWR)
JFNCX vs IWR Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWR has a market cap of 57B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWR trades at $109.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWR's P/E ratio is 23.12. In terms of profitability, JFNCX's ROE is N/A, compared to IWR's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IWR. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWR's competition here
Vanguard Russell 1000 Growth ETF (NASDAQ: VONG)
JFNCX vs VONG Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VONG has a market cap of 52B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VONG trades at $121.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VONG's P/E ratio is 30.80. In terms of profitability, JFNCX's ROE is N/A, compared to VONG's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VONG. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VONG's competition here
iShares S&P 500 Value ETF (AMEX: IVE)
JFNCX vs IVE Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IVE has a market cap of 48.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IVE trades at $231.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IVE's P/E ratio is 23.98. In terms of profitability, JFNCX's ROE is N/A, compared to IVE's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IVE. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IVE's competition here
iShares Russell 1000 ETF (AMEX: IWB)
JFNCX vs IWB Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWB has a market cap of 47.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWB trades at $404.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWB's P/E ratio is 26.31. In terms of profitability, JFNCX's ROE is N/A, compared to IWB's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IWB. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWB's competition here
State Street SPDR Portfolio Developed World ex-US ETF (AMEX: SPDW)
JFNCX vs SPDW Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SPDW has a market cap of 39.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SPDW trades at $49.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SPDW's P/E ratio is 18.00. In terms of profitability, JFNCX's ROE is N/A, compared to SPDW's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SPDW. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SPDW's competition here
Vanguard FTSE Europe ETF (AMEX: VGK)
JFNCX vs VGK Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VGK has a market cap of 37.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VGK trades at $88.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VGK's P/E ratio is 17.80. In terms of profitability, JFNCX's ROE is N/A, compared to VGK's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VGK. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VGK's competition here
State Street SPDR Portfolio S&P 500 Value ETF (AMEX: SPYV)
JFNCX vs SPYV Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SPYV has a market cap of 36B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SPYV trades at $61.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SPYV's P/E ratio is 23.29. In terms of profitability, JFNCX's ROE is N/A, compared to SPYV's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SPYV. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SPYV's competition here
American Funds Global Balanced Fd Cl F-1 (NASDAQ: GBLEX)
JFNCX vs GBLEX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, GBLEX has a market cap of 33B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while GBLEX trades at $42.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas GBLEX's P/E ratio is 21.56. In terms of profitability, JFNCX's ROE is N/A, compared to GBLEX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to GBLEX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check GBLEX's competition here
iShares MSCI Emerging Markets ETF (AMEX: EEM)
JFNCX vs EEM Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, EEM has a market cap of 29.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while EEM trades at $63.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas EEM's P/E ratio is 16.77. In terms of profitability, JFNCX's ROE is N/A, compared to EEM's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to EEM. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check EEM's competition here
State Street SPDR S&P MIDCAP 400 ETF Trust (AMEX: MDY)
JFNCX vs MDY Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, MDY has a market cap of 28.1B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while MDY trades at $690.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas MDY's P/E ratio is 22.08. In terms of profitability, JFNCX's ROE is N/A, compared to MDY's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to MDY. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check MDY's competition here
Vanguard S&P 500 Growth ETF (AMEX: VOOG)
JFNCX vs VOOG Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VOOG has a market cap of 25.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VOOG trades at $79.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VOOG's P/E ratio is 29.89. In terms of profitability, JFNCX's ROE is N/A, compared to VOOG's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VOOG. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VOOG's competition here
Avantis Emerging Markets Equity ETF (AMEX: AVEM)
JFNCX vs AVEM Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, AVEM has a market cap of 25.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while AVEM trades at $89.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas AVEM's P/E ratio is 14.54. In terms of profitability, JFNCX's ROE is N/A, compared to AVEM's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to AVEM. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check AVEM's competition here
iShares MSCI Emerging Markets ex China ETF (NASDAQ: EMXC)
JFNCX vs EMXC Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, EMXC has a market cap of 25.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while EMXC trades at $91.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas EMXC's P/E ratio is 18.33. In terms of profitability, JFNCX's ROE is N/A, compared to EMXC's ROE of N/A. Regarding short-term risk, JFNCX is less volatile compared to EMXC. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check EMXC's competition here
Schwab Fundamental International Large Company Index ETF (AMEX: FNDF)
JFNCX vs FNDF Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, FNDF has a market cap of 23.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while FNDF trades at $52.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas FNDF's P/E ratio is 16.69. In terms of profitability, JFNCX's ROE is N/A, compared to FNDF's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to FNDF. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check FNDF's competition here
iShares MSCI Japan ETF (AMEX: EWJ)
JFNCX vs EWJ Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, EWJ has a market cap of 21.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while EWJ trades at $91.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas EWJ's P/E ratio is 18.75. In terms of profitability, JFNCX's ROE is N/A, compared to EWJ's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to EWJ. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check EWJ's competition here
Vanguard Russell 1000 Value ETF (NASDAQ: VONV)
JFNCX vs VONV Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VONV has a market cap of 21.5B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VONV trades at $108.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VONV's P/E ratio is 22.85. In terms of profitability, JFNCX's ROE is N/A, compared to VONV's ROE of N/A. Regarding short-term risk, JFNCX is less volatile compared to VONV. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VONV's competition here
American Funds Global Insight Fund Class F-1 (NASDAQ: AGVEX)
JFNCX vs AGVEX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, AGVEX has a market cap of 21.5B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while AGVEX trades at $30.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas AGVEX's P/E ratio is 27.15. In terms of profitability, JFNCX's ROE is N/A, compared to AGVEX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to AGVEX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check AGVEX's competition here
Invesco S&P 500 Quality ETF (AMEX: SPHQ)
JFNCX vs SPHQ Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SPHQ has a market cap of 20.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SPHQ trades at $84.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SPHQ's P/E ratio is 27.62. In terms of profitability, JFNCX's ROE is N/A, compared to SPHQ's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SPHQ. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SPHQ's competition here
Dimensional - International Value ETF (AMEX: DFIV)
JFNCX vs DFIV Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, DFIV has a market cap of 19.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while DFIV trades at $55.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas DFIV's P/E ratio is 15.13. In terms of profitability, JFNCX's ROE is N/A, compared to DFIV's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to DFIV. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check DFIV's competition here
iShares Russell Mid-Cap Growth ETF (AMEX: IWP)
JFNCX vs IWP Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWP has a market cap of 19.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWP trades at $136.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWP's P/E ratio is 30.59. In terms of profitability, JFNCX's ROE is N/A, compared to IWP's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IWP. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWP's competition here
iShares Russell 3000 ETF (AMEX: IWV)
JFNCX vs IWV Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWV has a market cap of 19.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWV trades at $420.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWV's P/E ratio is 26.03. In terms of profitability, JFNCX's ROE is N/A, compared to IWV's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IWV. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWV's competition here
Avantis International Small Cap Value ETF (AMEX: AVDV)
JFNCX vs AVDV Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, AVDV has a market cap of 18.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while AVDV trades at $104.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas AVDV's P/E ratio is 13.25. In terms of profitability, JFNCX's ROE is N/A, compared to AVDV's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to AVDV. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check AVDV's competition here
iShares ESG Aware MSCI USA ETF (NASDAQ: ESGU)
JFNCX vs ESGU Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, ESGU has a market cap of 17.5B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while ESGU trades at $162.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas ESGU's P/E ratio is 26.73. In terms of profitability, JFNCX's ROE is N/A, compared to ESGU's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to ESGU. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check ESGU's competition here
State Street SPDR Portfolio Emerging Markets ETF (AMEX: SPEM)
JFNCX vs SPEM Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SPEM has a market cap of 17B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SPEM trades at $50.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SPEM's P/E ratio is 16.09. In terms of profitability, JFNCX's ROE is N/A, compared to SPEM's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SPEM. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SPEM's competition here
Dimensional - International Core Equity Market ETF (AMEX: DFAI)
JFNCX vs DFAI Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, DFAI has a market cap of 16.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while DFAI trades at $41.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas DFAI's P/E ratio is 17.93. In terms of profitability, JFNCX's ROE is N/A, compared to DFAI's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to DFAI. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check DFAI's competition here
Fidelity MSCI Information Technology Index ETF (AMEX: FTEC)
JFNCX vs FTEC Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, FTEC has a market cap of 16.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while FTEC trades at $270.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas FTEC's P/E ratio is 31.96. In terms of profitability, JFNCX's ROE is N/A, compared to FTEC's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to FTEC. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check FTEC's competition here
iShares Russell Mid-Cap Value ETF (AMEX: IWS)
JFNCX vs IWS Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWS has a market cap of 15.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWS trades at $166.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWS's P/E ratio is 21.82. In terms of profitability, JFNCX's ROE is N/A, compared to IWS's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IWS. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWS's competition here
Invesco S&P 500 Momentum ETF (AMEX: SPMO)
JFNCX vs SPMO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SPMO has a market cap of 15.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SPMO trades at $146.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SPMO's P/E ratio is 31.17. In terms of profitability, JFNCX's ROE is N/A, compared to SPMO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SPMO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SPMO's competition here
iShares Russell 2000 Value ETF (AMEX: IWN)
JFNCX vs IWN Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWN has a market cap of 14.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWN trades at $221.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWN's P/E ratio is 16.57. In terms of profitability, JFNCX's ROE is N/A, compared to IWN's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IWN. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWN's competition here
iShares Russell 2000 Growth ETF (AMEX: IWO)
JFNCX vs IWO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IWO has a market cap of 14.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IWO trades at $370.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IWO's P/E ratio is 23.79. In terms of profitability, JFNCX's ROE is N/A, compared to IWO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IWO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IWO's competition here
Vanguard FTSE All-World ex-US Small-Cap ETF (AMEX: VSS)
JFNCX vs VSS Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VSS has a market cap of 13.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VSS trades at $150.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VSS's P/E ratio is 15.83. In terms of profitability, JFNCX's ROE is N/A, compared to VSS's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VSS. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VSS's competition here
iShares MSCI Intl Quality Factor ETF (AMEX: IQLT)
JFNCX vs IQLT Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IQLT has a market cap of 13.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IQLT trades at $49.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IQLT's P/E ratio is 19.56. In terms of profitability, JFNCX's ROE is N/A, compared to IQLT's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IQLT. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IQLT's competition here
Vanguard FTSE Pacific ETF (AMEX: VPL)
JFNCX vs VPL Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VPL has a market cap of 13.5B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VPL trades at $108.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VPL's P/E ratio is 17.59. In terms of profitability, JFNCX's ROE is N/A, compared to VPL's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VPL. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VPL's competition here
iShares MSCI EAFE Small-Cap ETF (NASDAQ: SCZ)
JFNCX vs SCZ Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SCZ has a market cap of 13.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SCZ trades at $82.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SCZ's P/E ratio is 15.31. In terms of profitability, JFNCX's ROE is N/A, compared to SCZ's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SCZ. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SCZ's competition here
Lazard Global Listed Infrastructure Portfolio Institutional Shares (NASDAQ: GLIFX)
JFNCX vs GLIFX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, GLIFX has a market cap of 12.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while GLIFX trades at $19.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas GLIFX's P/E ratio is 20.03. In terms of profitability, JFNCX's ROE is N/A, compared to GLIFX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to GLIFX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check GLIFX's competition here
Lazard Global Listed Infrastructure Portfolio Open Shares (NASDAQ: GLFOX)
JFNCX vs GLFOX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, GLFOX has a market cap of 12.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while GLFOX trades at $19.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas GLFOX's P/E ratio is 20.02. In terms of profitability, JFNCX's ROE is N/A, compared to GLFOX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to GLFOX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check GLFOX's competition here
iShares MSCI South Korea ETF (AMEX: EWY)
JFNCX vs EWY Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, EWY has a market cap of 12.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while EWY trades at $162.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas EWY's P/E ratio is 93.19. In terms of profitability, JFNCX's ROE is N/A, compared to EWY's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to EWY. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check EWY's competition here
Schwab Emerging Markets Equity ETF (AMEX: SCHE)
JFNCX vs SCHE Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SCHE has a market cap of 12.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SCHE trades at $35.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SCHE's P/E ratio is 16.47. In terms of profitability, JFNCX's ROE is N/A, compared to SCHE's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SCHE. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SCHE's competition here
Capital Group Global Growth Equity ETF (AMEX: CGGO)
JFNCX vs CGGO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, CGGO has a market cap of 11.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while CGGO trades at $39.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas CGGO's P/E ratio is 21.80. In terms of profitability, JFNCX's ROE is N/A, compared to CGGO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to CGGO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check CGGO's competition here
iShares ESG Aware MSCI EAFE ETF (NASDAQ: ESGD)
JFNCX vs ESGD Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, ESGD has a market cap of 11.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while ESGD trades at $102.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas ESGD's P/E ratio is 18.81. In terms of profitability, JFNCX's ROE is N/A, compared to ESGD's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to ESGD. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check ESGD's competition here
iShares MSCI ACWI ex U.S. ETF (NASDAQ: ACWX)
JFNCX vs ACWX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, ACWX has a market cap of 11.5B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while ACWX trades at $74.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas ACWX's P/E ratio is 17.95. In terms of profitability, JFNCX's ROE is N/A, compared to ACWX's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to ACWX. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check ACWX's competition here
Vanguard Russell 1000 ETF (NASDAQ: VONE)
JFNCX vs VONE Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VONE has a market cap of 11.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VONE trades at $334.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VONE's P/E ratio is 26.13. In terms of profitability, JFNCX's ROE is N/A, compared to VONE's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VONE. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VONE's competition here
Janus Henderson Global Technology and Innovation Fund (NASDAQ: JATSX)
JFNCX vs JATSX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JATSX has a market cap of 11.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JATSX trades at $74.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JATSX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JATSX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JATSX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JATSX's competition here
Janus Henderson Global Technology and Innovation Fund Class C (NASDAQ: JAGCX)
JFNCX vs JAGCX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JAGCX has a market cap of 11.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JAGCX trades at $60.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JAGCX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JAGCX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JAGCX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JAGCX's competition here
Janus Henderson Global Technology and Innovation Fund T Shares (NASDAQ: JAGTX)
JFNCX vs JAGTX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JAGTX has a market cap of 11.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JAGTX trades at $81.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JAGTX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JAGTX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JAGTX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JAGTX's competition here
Janus Henderson Global Technology and Innovation Fund Class A (NASDAQ: JATAX)
JFNCX vs JATAX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JATAX has a market cap of 11.1B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JATAX trades at $78.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JATAX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JATAX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JATAX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JATAX's competition here
JPMorgan International Research Enhanced Equity ETF (AMEX: JIRE)
JFNCX vs JIRE Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JIRE has a market cap of 11B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JIRE trades at $81.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JIRE's P/E ratio is 18.26. In terms of profitability, JFNCX's ROE is N/A, compared to JIRE's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to JIRE. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check JIRE's competition here
iShares Global Infrastructure ETF (NASDAQ: IGF)
JFNCX vs IGF Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IGF has a market cap of 10.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IGF trades at $67.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IGF's P/E ratio is 22.46. In terms of profitability, JFNCX's ROE is N/A, compared to IGF's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IGF. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IGF's competition here
Fidelity Nasdaq Composite Index ETF (NASDAQ: ONEQ)
JFNCX vs ONEQ Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, ONEQ has a market cap of 10.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while ONEQ trades at $98.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas ONEQ's P/E ratio is 28.95. In terms of profitability, JFNCX's ROE is N/A, compared to ONEQ's ROE of N/A. Regarding short-term risk, JFNCX is less volatile compared to ONEQ. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check ONEQ's competition here
Invesco S&P 500 Top 50 ETF (AMEX: XLG)
JFNCX vs XLG Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, XLG has a market cap of 10B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while XLG trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas XLG's P/E ratio is 27.47. In terms of profitability, JFNCX's ROE is N/A, compared to XLG's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to XLG. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check XLG's competition here
ClearBridge Large Cap Growth IS (NASDAQ: LSITX)
JFNCX vs LSITX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, LSITX has a market cap of 9.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while LSITX trades at $73.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas LSITX's P/E ratio is 31.04. In terms of profitability, JFNCX's ROE is N/A, compared to LSITX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to LSITX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check LSITX's competition here
First Trust Nasdaq Cybersecurity ETF (NASDAQ: CIBR)
JFNCX vs CIBR Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, CIBR has a market cap of 9.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while CIBR trades at $88.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas CIBR's P/E ratio is 33.16. In terms of profitability, JFNCX's ROE is N/A, compared to CIBR's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to CIBR. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check CIBR's competition here
Dimensional - Emerging Markets Core Equity 2 ETF (AMEX: DFEM)
JFNCX vs DFEM Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, DFEM has a market cap of 9.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while DFEM trades at $37.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas DFEM's P/E ratio is 16.22. In terms of profitability, JFNCX's ROE is N/A, compared to DFEM's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to DFEM. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check DFEM's competition here
Schwab Fundamental U.S. Small Company Index ETF (AMEX: FNDA)
JFNCX vs FNDA Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, FNDA has a market cap of 9.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while FNDA trades at $37.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas FNDA's P/E ratio is 20.12. In terms of profitability, JFNCX's ROE is N/A, compared to FNDA's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to FNDA. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check FNDA's competition here
Invesco S&P 500 Revenue ETF (AMEX: RWL)
JFNCX vs RWL Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, RWL has a market cap of 9.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while RWL trades at $130.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas RWL's P/E ratio is 19.89. In terms of profitability, JFNCX's ROE is N/A, compared to RWL's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to RWL. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check RWL's competition here
Global X - Artificial Intelligence & Technology ETF (NASDAQ: AIQ)
JFNCX vs AIQ Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, AIQ has a market cap of 9.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while AIQ trades at $57.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas AIQ's P/E ratio is 25.11. In terms of profitability, JFNCX's ROE is N/A, compared to AIQ's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to AIQ. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check AIQ's competition here
Schwab Fundamental Emerging Markets Large Company Index ETF (AMEX: FNDE)
JFNCX vs FNDE Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, FNDE has a market cap of 9.1B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while FNDE trades at $40.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas FNDE's P/E ratio is 12.28. In terms of profitability, JFNCX's ROE is N/A, compared to FNDE's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to FNDE. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check FNDE's competition here
Xtrackers MSCI EAFE Hedged Equity ETF (AMEX: DBEF)
JFNCX vs DBEF Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, DBEF has a market cap of 9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while DBEF trades at $54.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas DBEF's P/E ratio is 19.14. In terms of profitability, JFNCX's ROE is N/A, compared to DBEF's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to DBEF. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check DBEF's competition here
iShares Global Tech ETF (AMEX: IXN)
JFNCX vs IXN Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IXN has a market cap of 8.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IXN trades at $132.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IXN's P/E ratio is 30.83. In terms of profitability, JFNCX's ROE is N/A, compared to IXN's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IXN. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IXN's competition here
American Funds Global Growth Portfolio Class F-1 (NASDAQ: PGGFX)
JFNCX vs PGGFX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, PGGFX has a market cap of 8.1B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while PGGFX trades at $28.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas PGGFX's P/E ratio is 25.64. In terms of profitability, JFNCX's ROE is N/A, compared to PGGFX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to PGGFX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check PGGFX's competition here
iShares MSCI World ETF (AMEX: URTH)
JFNCX vs URTH Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, URTH has a market cap of 7.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while URTH trades at $200.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas URTH's P/E ratio is 23.88. In terms of profitability, JFNCX's ROE is N/A, compared to URTH's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to URTH. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check URTH's competition here
Invesco S&P MidCap Momentum ETF (AMEX: XMMO)
JFNCX vs XMMO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, XMMO has a market cap of 7.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while XMMO trades at $160.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas XMMO's P/E ratio is 29.69. In terms of profitability, JFNCX's ROE is N/A, compared to XMMO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to XMMO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check XMMO's competition here
VictoryShares Free Cash Flow ETF (NASDAQ: VFLO)
JFNCX vs VFLO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VFLO has a market cap of 7.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VFLO trades at $48.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VFLO's P/E ratio is 19.73. In terms of profitability, JFNCX's ROE is N/A, compared to VFLO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VFLO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VFLO's competition here
DFA Global Real Estate Securities Port (NASDAQ: DFGEX)
JFNCX vs DFGEX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, DFGEX has a market cap of 7.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while DFGEX trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas DFGEX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to DFGEX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to DFGEX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check DFGEX's competition here
Vanguard Global Equity Fund (NASDAQ: VHGEX)
JFNCX vs VHGEX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VHGEX has a market cap of 7.6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VHGEX trades at $40.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VHGEX's P/E ratio is 22.72. In terms of profitability, JFNCX's ROE is N/A, compared to VHGEX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to VHGEX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check VHGEX's competition here
WisdomTree Japan Hedged Equity Fund (AMEX: DXJ)
JFNCX vs DXJ Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, DXJ has a market cap of 7.2B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while DXJ trades at $176.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas DXJ's P/E ratio is 17.86. In terms of profitability, JFNCX's ROE is N/A, compared to DXJ's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to DXJ. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check DXJ's competition here
Invesco S&P 500 Low Volatility ETF (AMEX: SPLV)
JFNCX vs SPLV Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, SPLV has a market cap of 7.1B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while SPLV trades at $77.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas SPLV's P/E ratio is 21.82. In terms of profitability, JFNCX's ROE is N/A, compared to SPLV's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to SPLV. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check SPLV's competition here
Fidelity Enhanced International ETF (AMEX: FENI)
JFNCX vs FENI Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, FENI has a market cap of 7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while FENI trades at $39.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas FENI's P/E ratio is 16.82. In terms of profitability, JFNCX's ROE is N/A, compared to FENI's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to FENI. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check FENI's competition here
JPMorgan Global Select Equity ETF (NASDAQ: JGLO)
JFNCX vs JGLO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JGLO has a market cap of 6.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JGLO trades at $70.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JGLO's P/E ratio is 23.79. In terms of profitability, JFNCX's ROE is N/A, compared to JGLO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to JGLO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check JGLO's competition here
iShares ESG Aware MSCI EM ETF (NASDAQ: ESGE)
JFNCX vs ESGE Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, ESGE has a market cap of 6.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while ESGE trades at $50.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas ESGE's P/E ratio is 17.18. In terms of profitability, JFNCX's ROE is N/A, compared to ESGE's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to ESGE. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check ESGE's competition here
Vanguard S&P 500 Value ETF (AMEX: VOOV)
JFNCX vs VOOV Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VOOV has a market cap of 6.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VOOV trades at $223.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VOOV's P/E ratio is 23.33. In terms of profitability, JFNCX's ROE is N/A, compared to VOOV's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VOOV. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VOOV's competition here
Vanguard S&P Small-Cap 600 ETF (AMEX: VIOO)
JFNCX vs VIOO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VIOO has a market cap of 6.4B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VIOO trades at $134.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VIOO's P/E ratio is 19.11. In terms of profitability, JFNCX's ROE is N/A, compared to VIOO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VIOO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VIOO's competition here
T. Rowe Price Global Technology Fund (NASDAQ: PRGTX)
JFNCX vs PRGTX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, PRGTX has a market cap of 6.3B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while PRGTX trades at $33.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas PRGTX's P/E ratio is 46.70. In terms of profitability, JFNCX's ROE is N/A, compared to PRGTX's ROE of +0.14%. Regarding short-term risk, JFNCX is similarly volatile compared to PRGTX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check PRGTX's competition here
Capital Group International Focus Equity ETF (AMEX: CGXU)
JFNCX vs CGXU Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, CGXU has a market cap of 6.1B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while CGXU trades at $33.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas CGXU's P/E ratio is 18.21. In terms of profitability, JFNCX's ROE is N/A, compared to CGXU's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to CGXU. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check CGXU's competition here
Vanguard Russell 3000 ETF (NASDAQ: VTHR)
JFNCX vs VTHR Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, VTHR has a market cap of 6B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while VTHR trades at $326.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas VTHR's P/E ratio is 25.87. In terms of profitability, JFNCX's ROE is N/A, compared to VTHR's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to VTHR. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check VTHR's competition here
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX)
JFNCX vs JAGLX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JAGLX has a market cap of 5.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JAGLX trades at $87.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JAGLX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JAGLX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JAGLX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JAGLX's competition here
Janus Henderson Global Life Sciences Fund Class N Shares (NASDAQ: JFNNX)
JFNCX vs JFNNX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JFNNX has a market cap of 5.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JFNNX trades at $88.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JFNNX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JFNNX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JFNNX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JFNNX's competition here
Vanguard S&P Mid-Cap 400 ETF (AMEX: IVOO)
JFNCX vs IVOO Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, IVOO has a market cap of 5.9B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while IVOO trades at $128.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas IVOO's P/E ratio is 22.12. In terms of profitability, JFNCX's ROE is N/A, compared to IVOO's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to IVOO. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check IVOO's competition here
Janus Henderson Global Life Sciences Fund (NASDAQ: JNGLX)
JFNCX vs JNGLX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JNGLX has a market cap of 5.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JNGLX trades at $88.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JNGLX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JNGLX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JNGLX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JNGLX's competition here
Janus Henderson Global Life Sciences Fund Class S (NASDAQ: JFNSX)
JFNCX vs JFNSX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JFNSX has a market cap of 5.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JFNSX trades at $83.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JFNSX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JFNSX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JFNSX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JFNSX's competition here
Janus Henderson Global Life Sciences Fund (NASDAQ: JFNIX)
JFNCX vs JFNIX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, JFNIX has a market cap of 5.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while JFNIX trades at $88.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas JFNIX's P/E ratio is N/A. In terms of profitability, JFNCX's ROE is N/A, compared to JFNIX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to JFNIX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check JFNIX's competition here
Columbia Global Technology Growth Fund Class C (NASDAQ: CTHCX)
JFNCX vs CTHCX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, CTHCX has a market cap of 5.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while CTHCX trades at $103.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas CTHCX's P/E ratio is 35.60. In terms of profitability, JFNCX's ROE is N/A, compared to CTHCX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to CTHCX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check CTHCX's competition here
iShares MSCI China ETF (NASDAQ: MCHI)
JFNCX vs MCHI Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, MCHI has a market cap of 5.8B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while MCHI trades at $53.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas MCHI's P/E ratio is 12.70. In terms of profitability, JFNCX's ROE is N/A, compared to MCHI's ROE of +0.00%. Regarding short-term risk, JFNCX is less volatile compared to MCHI. This indicates lower risk in terms of short-term price fluctuations for JFNCX.Check MCHI's competition here
Columbia Global Technology Growth Fund (NASDAQ: CMTFX)
JFNCX vs CMTFX Comparison July 2026
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JFNCX stands at 5.9B. In comparison, CMTFX has a market cap of 5.7B. Regarding current trading prices, JFNCX is priced at $73.21 on the NASDAQ, while CMTFX trades at $132.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JFNCX currently has a P/E ratio of N/A, whereas CMTFX's P/E ratio is 35.65. In terms of profitability, JFNCX's ROE is N/A, compared to CMTFX's ROE of N/A. Regarding short-term risk, JFNCX is similarly volatile compared to CMTFX. This indicates similar risk in terms of short-term price fluctuations for JFNCX.Check CMTFX's competition here